Novartis Serbia

Novartis Serbia is the representative office of the Swiss company Novartis AG, established in 1997 in Belgrade. As part of the global network of one of the world's leading innovative pharmaceutical companies, Novartis has a mission to discover and advance medical breakthroughs that contribute to improving the quality and length of human life.

With more than 50 employees in four cities and over 100,000 patients treated annually with Novartis medicines in Serbia, the company ranks fifth among innovative pharmaceutical companies in the domestic market.

Globally, Novartis operates in five priority therapeutic areas – neurology, cardiology, immunology, oncology, and hematology – and has one of the most advanced research pipelines, with over 150 medicines in various stages of development. In Serbia, clinical trials of Novartis medicines have been successfully conducted since 2004, in cooperation with clinical centers throughout the country, giving more than 500 patients access to cutting-edge therapies in oncology, cardiology, hematology, nephrology, and respiratory diseases.

Novartis continuously invests in the development of Serbia's healthcare system, supporting medical education, digital solutions, strengthening healthcare infrastructure, and improving health literacy. Over the years, the company has supported healthcare institutions, professional associations, and patient organizations, including telemedicine projects, creating registries in therapeutic areas, and providing patient transportation during the COVID-19 pandemic.

Driven by a strong sense of social responsibility, Novartis has become a reliable partner in public healthcare, contributing not only to the development of therapies but also to creating a more sustainable, accessible, and humane healthcare system.

We thank Novartis Serbia for their support and trust, and for recognizing the importance of the patient navigation app for women with breast cancer. Their support contributes to the development of innovative digital healthcare solutions and better access to information, directly improving the quality of life of women with breast cancer throughout Serbia.